ACTRN12605000412639
Recruiting
Not Applicable
The Effect of Selenium Supplementation on Clinical Outcome in High Risk Cardiac Patients with Coronary Artery Disease
Dr Nathalie van Havre0 sites400 target enrollmentSeptember 15, 2005
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Coronary Artery Disease
- Sponsor
- Dr Nathalie van Havre
- Enrollment
- 400
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •3 vessel disease proven by angiography, with no percutaneous or surgical intervention since diagnosis.
Exclusion Criteria
- •Valvular heart disease.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
The effect of Selenium supplementation in high risk mothers for Preeclampsia screened with Quadruple testsIRCT20200608047701N1Kashan University of Medical Sciences60
Recruiting
Phase 3
effect of selenium in systemic lupus erythematosusIRCT20210717051914N2Ahvaz University of Medical Sciences56
Recruiting
Phase 2
Evaluation of the effect of selenium on patients with thyroid cancer treated with radioactive iodineThyroid cancer.Neoplasm of uncertain behavior of thyroid glandD44.0IRCT20201129049534N6Esfahan University of Medical Sciences60
Recruiting
Phase 3
The effect of selenium on cancer related-fatigueCancer-related fatigue.Neoplasm-related fatigueR53.0IRCT20210825052293N1Esfahan University of Medical Sciences70
Completed
Phase 4
The effect of selenium supplementation in moderate-to-severe thyroid eye disease patients : a randomized-placebo controlled trialModerate-to-severe thyroid eye disease patientsInactiveTCTR20170827002The Ratchadapiseksompotch Fund, Faculty of Medicine46